Dynamic PET/CT imaging of 18F-(2S, 4R)4-fluoroglutamine in healthy volunteers and oncological patients.

Abstract:

PURPOSE:The purpose of this study was to compare dynamic 18F-FGln PET/CT images of healthy subjects and cancer patients and explore the best imaging phase for different cancers. METHODS:Thirteen healthy volunteers and 31 cancer patients separately underwent 18F-FGln and 18F-FDG PET/CT scans within 1 week. The distributions of 18F-FGln and 18F-FDG in the whole body and the tumor avidity were analyzed and compared. The tumor maximum standardized uptake values (SUVmax) and tumor-to-nontumor SUV ratio (SUR) of 18F-FGln/PET at different scan phases were compared. RESULTS:Compared to the healthy subjects, the cancer patients had lower 18F-FGln activity (SUVmean) in most normal organs, especially in the lung, muscle, spleen, and heart (p < 0.05). Additionally, the FGln-avid tumors did not necessarily manifest as FDG-avid and vice versa. Overall, among the 31 primary malignant lesions confirmed by biopsy or postoperative pathological analysis, 29 showed increased radioactive uptake on all 18F-FGln PET/CT imaging phases. The peak of SUVmax in breast and thyroid cancers was within 10 min, while in lung cancers, the plateau of SUVmax was within 30 min to 60 min. The SURs of lung cancer (p = 0.046) and thyroid cancer (p = 0.794) increased from the early-phase to the late-phase acquisition; however, a significant decrease was observed in the breast lesions (p = 0.022). CONCLUSIONS:18F-FGln images may further supplement the diagnostic ability of 18F-FDG in cancer patients and detect metabolic changes in different tumors. Furthermore, the imaging time for 18F-FGln PET/CT needs to be optimized for different cancer types to improve the contrast resolution of tumors.

authors

Xu X,Zhu H,Liu F,Zhang Y,Yang J,Zhang L,Xie Q,Zhu L,Li N,Kung HF,Yang Z

doi

10.1007/s00259-019-04543-w

subject

Has Abstract

pub_date

2020-09-01 00:00:00

pages

2280-2292

issue

10

eissn

1619-7070

issn

1619-7089

pii

10.1007/s00259-019-04543-w

journal_volume

47

pub_type

杂志文章
  • Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F]PBR102 and [18F]PBR111.

    abstract:PURPOSE:To determine the metabolic profiles of the translocator protein ligands PBR102 and PBR111 in rat and human microsomes and compare their in vivo binding and metabolite uptake in the brain of non-human primates (Papio hamadryas) using PET-CT. METHODS:In vitro metabolic profiles of PBR102 and PBR111 in rat and hu...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-016-3517-z

    authors: Eberl S,Katsifis A,Peyronneau MA,Wen L,Henderson D,Loc'h C,Greguric I,Verschuer J,Pham T,Lam P,Mattner F,Mohamed A,Fulham MJ

    更新日期:2017-02-01 00:00:00

  • Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[(11)C]verapamil PET.

    abstract:PURPOSE:Overactivity of the multidrug efflux transporter P-glycoprotein (P-gp) at the blood-brain barrier (BBB) is believed to play an important role in resistance to central nervous system drug treatment. (R)-[(11)C]verapamil (VPM) PET can be used to measure the function of P-gp at the BBB, but low brain uptake of VPM...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-009-1332-5

    authors: Kuntner C,Bankstahl JP,Bankstahl M,Stanek J,Wanek T,Stundner G,Karch R,Brauner R,Meier M,Ding X,Müller M,Löscher W,Langer O

    更新日期:2010-05-01 00:00:00

  • ¹¹¹In-anti-F4/80-A3-1 antibody: a novel tracer to image macrophages.

    abstract:PURPOSE:Here, the expression of F4/80 on the cell surface of murine macrophages was exploited to develop a novel imaging tracer that could visualize macrophages in vivo. METHODS:The immunoreactive fraction and IC50 of anti-F4/80-A3-1, conjugated with diethylenetriaminepentaacetic acid (DTPA) and radiolabelled with (11...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-015-3084-8

    authors: Terry SY,Boerman OC,Gerrits D,Franssen GM,Metselaar JM,Lehmann S,Oyen WJ,Gerdes CA,Abiraj K

    更新日期:2015-08-01 00:00:00

  • Chronic ACE inhibitor treatment increases angiotensin type 1 receptor binding in vivo in the dog kidney.

    abstract:PURPOSE:PET imaging has been recently introduced for investigating the type 1 angiotensin II receptor (AT(1)R) in vivo. The goal of the present study was to investigate the effects of acute and chronic exposure to angiotensin converting enzyme inhibitors (ACEI) on the AT(1)R in the dog kidney. METHODS:Animals were ima...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-007-0667-z

    authors: Zober TG,Fabucci ME,Zheng W,Brown PR,Seckin E,Mathews WB,Sandberg K,Szabo Z

    更新日期:2008-06-01 00:00:00

  • Hypertension complicating 131I-meta-iodobenzylguanidine therapy for neuroblastoma.

    abstract:PURPOSE:Radiolabelled meta-iodobenzylguanidine (mIBG), used as targeted therapy for neuroblastoma, is known to have effects on blood pressure (BP). In this study we audited BP changes in patients receiving (131)I-mIBG therapy for neuroblastoma to identify BP-related adverse events (AE) and possible predictive factors. ...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-011-2022-7

    authors: Kosmin MA,Bomanji JB,Cork NJ,Shankar A,Gaze MN

    更新日期:2012-04-01 00:00:00

  • [N-methyl 11C]meta-Hydroxyephedrine positron emission tomography in Parkinson's disease and multiple system atrophy.

    abstract::Orthostatic hypotension (OH) can be present in idiopathic Parkinson's disease (IPD) as well as in atypical parkinsonian syndromes such as multiple system atrophy (MSA). According to clinical tests of sympathetic nerve function and histopathological data, OH is caused by primarily postganglionic sympathetic dysfunction...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00259-002-1019-7

    authors: Berding G,Schrader CH,Peschel T,van den Hoff J,Kolbe H,Meyer GJ,Dengler R,Knapp WH

    更新日期:2003-01-01 00:00:00

  • Effects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic heart disease.

    abstract:PURPOSE:We assessed the effects of the COVID-19 pandemic on myocardial perfusion imaging (MPI) for ischemic heart disease during the lockdown imposed by the Italian Government. METHODS:We retrospectively reviewed the number and the findings of stress single-photon emission computed tomography (SPECT)-MPI performed bet...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-020-04994-6

    authors: Nappi C,Megna R,Acampa W,Assante R,Zampella E,Gaudieri V,Mannarino T,Green R,Cantoni V,Petretta M,Cuocolo A

    更新日期:2021-02-01 00:00:00

  • Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes: a 1-year interim report of a J-ACCESS 2 investigation using myocardial perfusion imaging.

    abstract:PURPOSE:Diabetic patients have a high risk for cardiovascular events. The role of myocardial perfusion imaging was investigated in asymptomatic diabetic patients to evaluate short-term prognosis in a Japanese population. METHODS:A total of 506 asymptomatic patients ≥ 50 years of age who had carotid artery maximum inti...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-009-1207-9

    authors: Nakajima K,Yamasaki Y,Kusuoka H,Izumi T,Kashiwagi A,Kawamori R,Shimamoto K,Yamada N,Nishimura T

    更新日期:2009-12-01 00:00:00

  • Kinetic modeling and parametric imaging with dynamic PET for oncological applications: general considerations, current clinical applications, and future perspectives.

    abstract::Dynamic PET (dPET) studies have been used until now primarily within research purposes. Although it is generally accepted that the information provided by dPET is superior to that of conventional static PET acquisitions acquired usually 60 min post injection of the radiotracer, the duration of dynamic protocols, the l...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章,评审

    doi:10.1007/s00259-020-04843-6

    authors: Dimitrakopoulou-Strauss A,Pan L,Sachpekidis C

    更新日期:2021-01-01 00:00:00

  • Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT.

    abstract:PURPOSE:The aim of this study was to investigate the feasibility of assessing dopamine transporter binding after treatment with methylphenidate in the rat using a recently developed high-resolution small animal single-photon emission computed tomograph (TierSPECT) and [123I]FP-CIT. METHODS:[123I]FP-CIT was administere...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-004-1615-9

    authors: Nikolaus S,Wirrwar A,Antke C,Arkian S,Schramm N,Müller HW,Larisch R

    更新日期:2005-03-01 00:00:00

  • Specific efficacy of peptide receptor radionuclide therapy with (177)Lu-octreotate in advanced neuroendocrine tumours of the small intestine.

    abstract:PURPOSE:Increasing evidence supports the value of peptide receptor radionuclide therapy (PRRT) in patients with metastatic neuroendocrine tumours (NET), but there are limited data on its specific efficacy in NET of small intestinal (midgut) origin. This study aims to define the benefit of PRRT with (177)Lu-octreotate f...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-015-3041-6

    authors: Sabet A,Dautzenberg K,Haslerud T,Aouf A,Sabet A,Simon B,Mayer K,Biersack HJ,Ezziddin S

    更新日期:2015-07-01 00:00:00

  • Non-small-cell lung cancer resectability: diagnostic value of PET/MR.

    abstract:PURPOSE:To assess the diagnostic performance of PET/MR in patients with non-small-cell lung cancer. METHODS:Fifty consecutive consenting patients who underwent routine (18)F-FDG PET/CT for potentially radically treatable lung cancer following a staging CT scan were recruited for PET/MR imaging on the same day. Two exp...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-014-2873-9

    authors: Fraioli F,Screaton NJ,Janes SM,Win T,Menezes L,Kayani I,Syed R,Zaccagna F,O'Meara C,Barnes A,Bomanji JB,Punwani S,Groves AM

    更新日期:2015-01-01 00:00:00

  • Whole-body voxel-based internal dosimetry using deep learning.

    abstract:PURPOSE:In the era of precision medicine, patient-specific dose calculation using Monte Carlo (MC) simulations is deemed the gold standard technique for risk-benefit analysis of radiation hazards and correlation with patient outcome. Hence, we propose a novel method to perform whole-body personalized organ-level dosime...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-020-05013-4

    authors: Akhavanallaf A,Shiri I,Arabi H,Zaidi H

    更新日期:2020-09-01 00:00:00

  • Evaluation of iterative reconstruction (OSEM) versus filtered back-projection for the assessment of myocardial glucose uptake and myocardial perfusion using dynamic PET.

    abstract:PURPOSE:Iterative reconstruction methods based on ordered-subset expectation maximisation (OSEM) has replaced filtered backprojection (FBP) in many clinical settings owing to the superior image quality. Whether OSEM is as accurate as FBP in quantitative positron emission tomography (PET) is uncertain. We compared the a...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-006-0198-z

    authors: Søndergaard HM,Madsen MM,Boisen K,Bøttcher M,Schmitz O,Nielsen TT,Bøtker HE,Hansen SB

    更新日期:2007-03-01 00:00:00

  • Diagnostic performance of ¹⁸F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with ¹⁸F-fluorodeoxyglucose PET/CT.

    abstract:PURPOSE:To examine the diagnostic performance of (18)F-fluorothymidine (FLT) PET/CT in primary and metastatic lymph node colorectal cancer foci in comparison with (18)F-fluorodeoxyglucose (FDG) PET/CT. METHODS:The study population comprised 28 patients with 30 newly diagnosed colorectal cancers who underwent surgical ...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-013-2424-9

    authors: Nakajo M,Nakajo M,Kajiya Y,Jinguji M,Nishimata N,Shimaoka S,Nihara T,Aridome K,Tanaka S,Fukukura Y,Tani A,Koriyama C

    更新日期:2013-08-01 00:00:00

  • [(68)Ga]NODAGA-RGD - Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis.

    abstract:PURPOSE:This study was designed to determine safety, tolerability, and radiation burden of a [(68)Ga]NODAGA-RGD-PET for imaging integrin αvβ3 expression in patients with hepatocellular carcinoma (HCC) and liver cirrhosis. Moreover, metabolic stability and biokinetic data were compiled. METHODS:After injection of 154-1...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-016-3396-3

    authors: Haubner R,Finkenstedt A,Stegmayr A,Rangger C,Decristoforo C,Zoller H,Virgolini IJ

    更新日期:2016-10-01 00:00:00

  • Reduced myocardial 18F-FDG uptake after calcium channel blocker administration. Initial observation for a potential new method to improve plaque detection.

    abstract:PURPOSE:Physiological glucose uptake by the myocardium may hamper visualization of coronary atherosclerotic plaques in (18)F-FDG PET studies. Intracellular myocardial calcium relates to glucose influx. We assessed whether administration of a calcium channel blocker such as verapamil could decrease myocardial (18)F-FDG ...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-011-1873-2

    authors: Gaeta C,Fernández Y,Pavía J,Flotats A,Artigas C,Deportos J,Geraldo L,Carrió I

    更新日期:2011-11-01 00:00:00

  • Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study.

    abstract:PURPOSE:Positron emission tomography (PET) was evaluated in low-grade non-Hodgkin lymphoma (NHL) to determine its impact on staging and management and to compare PET and gallium scans. METHODS:PET resulted in management plan changes in 74 patients with untreated low-grade NHL stages I to III. Patient outcomes to 12 mo...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s00259-008-0958-z

    authors: Scott AM,Gunawardana DH,Wong J,Kirkwood I,Hicks RJ,Ho Shon I,Ramshaw JE,Robins P

    更新日期:2009-03-01 00:00:00

  • Clinical utility of FDG PET/CT in acute complicated pyelonephritis-results from an observational study.

    abstract:BACKGROUND:Acute complicated pyelonephritis (ACP) is an upper urinary tract infection associated with coexisting urinary tract abnormalities or medical conditions that could predispose to serious outcomes or treatment failures. Although CT and magnetic resonance imaging (MRI) are frequently used in patients with ACP, t...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-017-3835-9

    authors: Wan CH,Tseng JR,Lee MH,Yang LY,Yen TC

    更新日期:2018-03-01 00:00:00

  • Comparison of bifunctional chelates for (64)Cu antibody imaging.

    abstract:PURPOSE:Improved bifunctional chelates (BFCs) are needed to facilitate efficient (64)Cu radiolabeling of monoclonal antibodies (mAbs) under mild conditions and to yield stable, target-specific agents. The utility of two novel BFCs, 1-Oxa-4,7,10-triazacyclododecane-5-S-(4-isothiocyanatobenzyl)-4,7,10-triacetic acid (p-S...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-010-1506-1

    authors: Ferreira CL,Yapp DT,Crisp S,Sutherland BW,Ng SS,Gleave M,Bensimon C,Jurek P,Kiefer GE

    更新日期:2010-11-01 00:00:00

  • SPECT and PET imaging of angiogenesis and arteriogenesis in pre-clinical models of myocardial ischemia and peripheral vascular disease.

    abstract:PURPOSE:The extent of neovascularization determines the clinical outcome of coronary artery disease and other occlusive cardiovascular disorders. Monitoring of neovascularization is therefore highly important. This review article will elaborately discuss preclinical studies aimed at validating new nuclear angiogenesis ...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章,评审

    doi:10.1007/s00259-016-3480-8

    authors: Hendrikx G,Vöö S,Bauwens M,Post MJ,Mottaghy FM

    更新日期:2016-12-01 00:00:00

  • Rhenium-188 labelled meso-tetrakis[3,4-bis(carboxymethyleneoxy)phenyl] porphyrin for targeted radiotherapy: preliminary biological evaluation in mice.

    abstract:PURPOSE:This study focusses on a promising carrier system for therapeutic and imaging purposes using meso-tetrakis[3,4-bis(carboxymethyleneoxy)phenyl] porphyrin (T(3,4)CPP). To assess its potential for clinical use, we labelled T(3,4)CPP with (188)Re and analysed some kinetic biodistribution parameters after intravenou...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-007-0682-0

    authors: Jia ZY,Deng HF,Pu MF,Luo SZ

    更新日期:2008-04-01 00:00:00

  • Delayed response after repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer.

    abstract:PURPOSE:Radioligand therapy (RLT) using Lutetium-177 labeled PSMA-617 (Lu-PSMA) ligand is a new therapeutic option for salvage therapy in heavily pretreated patients with metastatic castration resistant prostate cancer. The aim of this retrospective study was to analyze response in patients receiving 3 cycles of Lu-PSM...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-017-3877-z

    authors: Rahbar K,Bögeman M,Yordanova A,Eveslage M,Schäfers M,Essler M,Ahmadzadehfar H

    更新日期:2018-02-01 00:00:00

  • Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer.

    abstract:PURPOSE:Diffusion-weighted magnetic resonance imaging (DWI) and fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) are oncological feasible techniques. Currently, apparent diffusion coefficient (ADC) measured by DWI and standard uptake value (SUV) from FDG PET/CT have similar applications ...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-008-0936-5

    authors: Ho KC,Lin G,Wang JJ,Lai CH,Chang CJ,Yen TC

    更新日期:2009-02-01 00:00:00

  • Monoamine transporter availability in Parkinson's disease patients with or without depression.

    abstract:PURPOSE:Depression is a common symptom in patients suffering from Parkinson's disease (PD) and markedly reduces their quality of life. As post-mortem studies have shown, its presence may reflect extensive cell loss in the midbrain and brainstem with imbalances in monoaminergic neurotransmitters. However, in vivo eviden...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-008-0979-7

    authors: Hesse S,Meyer PM,Strecker K,Barthel H,Wegner F,Oehlwein C,Isaias IU,Schwarz J,Sabri O

    更新日期:2009-03-01 00:00:00

  • Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.

    abstract:PURPOSE:The aim of this study was to investigate metabolic and textural parameters from pretreatment [(18)F]FDG PET/CT scans for the prediction of neoadjuvant radiation chemotherapy response and 3-year disease-free survival (DFS) in patients with locally advanced rectal cancer (LARC). METHODS:We performed a retrospect...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-015-3180-9

    authors: Bang JI,Ha S,Kang SB,Lee KW,Lee HS,Kim JS,Oh HK,Lee HY,Kim SE

    更新日期:2016-03-01 00:00:00

  • Investigation into the mechanisms of vagus nerve stimulation for the treatment of intractable epilepsy, using 99mTc-HMPAO SPET brain images.

    abstract::Vagus nerve stimulation (VNS) has gained recognition as a treatment for refractory epilepsies where surgical treatment is not possible. While it appears that this treatment is effective in some patients, the mechanism of action is not clearly understood. The purpose of this study was to clarify findings of other posit...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00259-002-1026-8

    authors: Barnes A,Duncan R,Chisholm JA,Lindsay K,Patterson J,Wyper D

    更新日期:2003-02-01 00:00:00

  • Bone metabolic activity in hyperostosis cranialis interna measured with 18F-fluoride PET.

    abstract:PURPOSE:(18)F-Fluoride PET/CT is a relatively undervalued diagnostic test to measure bone metabolism in bone diseases. Hyperostosis cranialis interna (HCI) is a (hereditary) bone disease characterised by endosteal hyperostosis and osteosclerosis of the skull and the skull base. Bone overgrowth causes entrapment and dys...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-010-1655-2

    authors: Waterval JJ,Van Dongen TM,Stokroos RJ,Teule JG,Kemerink GJ,Brans B,Nieman FH,Manni JJ

    更新日期:2011-05-01 00:00:00

  • Influence of lanreotide on uptake of 68Ga-DOTATATE in patients with neuroendocrine tumours: a prospective intra-patient evaluation.

    abstract:INTRODUCTION:Somatostatin receptor imaging with PET is the standard of care for patients with a neuroendocrine tumour (NET). Since therapy and imaging with somatostatin analogues utilize the same receptor, current guidelines recommend withdrawing long-acting somatostatin analogues for 3-4 weeks prior to somatostatin re...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00259-018-4117-x

    authors: Aalbersberg EA,de Wit-van der Veen BJ,Versleijen MWJ,Saveur LJ,Valk GD,Tesselaar MET,Stokkel MPM

    更新日期:2019-03-01 00:00:00

  • Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease.

    abstract:PURPOSE:To compare the incremental diagnostic value of amyloid-PET and CSF (Aβ42, tau, and phospho-tau) in AD diagnosis in patients with mild cognitive impairment (MCI) or mild dementia, in order to improve the definition of diagnostic algorithm. METHODS:Two independent dementia experts provided etiological diagnosis ...

    journal_title:European journal of nuclear medicine and molecular imaging

    pub_type: 杂志文章

    doi:10.1007/s00259-019-04466-6

    authors: Ramusino MC,Garibotto V,Bacchin R,Altomare D,Dodich A,Assal F,Mendes A,Costa A,Tinazzi M,Morbelli SD,Bauckneht M,Picco A,Dottorini ME,Tranfaglia C,Farotti L,Salvadori N,Moretti D,Savelli G,Tarallo A,Nobili F,Parap

    更新日期:2020-02-01 00:00:00